{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:19:24Z","timestamp":1761895164691},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ejim.2010.08.010","type":"journal-article","created":{"date-parts":[[2010,9,20]],"date-time":"2010-09-20T08:14:47Z","timestamp":1284970487000},"page":"564-568","source":"Crossref","is-referenced-by-count":2,"title":["Survival of cancer patients with prior monoclonal gammopathy of undetermined significance"],"prefix":"10.1016","volume":"21","author":[{"given":"Henrik","family":"Gregersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik Toft","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malene Cramer","family":"Engebjerg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paw","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne Tang","family":"Severinsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"N\u00f8rgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2010.08.010_bb0005","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2010.08.010_bb0010","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2010.08.010_bb0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2141.1992.tb08245.x","article-title":"Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance","volume":"81","author":"Blade","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2010.08.010_bb0020","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2141.2001.02533.x","article-title":"Mortality and causes of death in patients with monoclonal gammopathy of undetermined significance","volume":"112","author":"Gregersen","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2010.08.010_bb0025","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2141.2008.07423.x","article-title":"Long-term follow-up of a population based cohort with monoclonal proteinaemia","volume":"144","author":"Schaar","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2010.08.010_bb0030","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3324\/haematol.2009.010066","article-title":"Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance (MGUS): a population-based study","volume":"94","author":"Kristinsson","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.ejim.2010.08.010_bb0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000203676","article-title":"The natural history of monoclonal gammopathy of undetermined significance. A 5- to 20-year follow-up of 263 cases","volume":"97","author":"Pasqualetti","year":"1997","journal-title":"Acta Haematol"},{"key":"10.1016\/j.ejim.2010.08.010_bb0040","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2141.2006.06441.x","article-title":"Complete response in myeloma extends survival without, but not with history of prior monoclonal gammopathy of undetermined significance or smouldering disease","volume":"136","author":"Pineda-Roman","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2010.08.010_bb0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2362.2007.01903.x","article-title":"Cytogenetic patterns in multiple myeloma after a phase of preceding MGUS","volume":"38","author":"Kaufmann","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejim.2010.08.010_bb0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2141.2008.07069.x","article-title":"Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders","volume":"141","author":"Kumar","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2010.08.010_bb0055","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/10428199909058488","article-title":"Clinical features and outcome of multiple myeloma arising from the transformation of a monoclonal gammapathy of undetermined significance","volume":"34","author":"Patriarca","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.ejim.2010.08.010_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8652(200001)63:1<1::AID-AJH1>3.0.CO;2-M","article-title":"Cancer risk in patients with monoclonal gammopathy of undetermined significance","volume":"63","author":"Gregersen","year":"2000","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2010.08.010_bb0065","series-title":"Fundamentals of cancer epidemiology","article-title":"Immunity and cancer risk","author":"Nasca","year":"2008"},{"key":"10.1016\/j.ejim.2010.08.010_bb0070","first-page":"221","article-title":"Immunocytoma, cancer and other associations of monoclonal gammopathy: a review of 224 cases","volume":"82","author":"Colls","year":"1975","journal-title":"N Z Med J"},{"key":"10.1016\/j.ejim.2010.08.010_bb0075","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1126\/science.287.5462.2398","article-title":"When an entire country is a cohort","volume":"287","author":"Epidemiology","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejim.2010.08.010_bb0080","first-page":"535","article-title":"The Danish Cancer Registry\u2014history, content, quality and use","volume":"44","author":"Storm","year":"1997","journal-title":"Dan Med Bull"},{"key":"10.1016\/j.ejim.2010.08.010_bb0085","first-page":"33","article-title":"Data validity and coverage in the Danish National Health Registry. A literature review","volume":"164","author":"Nickelsen","year":"2001","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.ejim.2010.08.010_bb0090","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ejim.2010.08.010_bb0095","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2010.08.010_bb0100","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","article-title":"A monoclonal gammopathy precedes multiple myeloma in most patients","volume":"113","author":"Weiss","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2010.08.010_bb0105","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1365-2141.2008.07530.x","article-title":"CD4(+)CD25(+)FoxP3(+) regulatory T cells are increased whilst CD3(+)CD4(\u2212)CD8(\u2212) alphabetaTCR(+) double negative T cells are decreased in the peripheral blood of patients with multiple myeloma which correlates with disease burden","volume":"144","author":"Feyler","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2010.08.010_bb0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood-2005-08-3101","article-title":"Dysfunctional T regulatory cells in multiple myeloma","volume":"107","author":"Prabhala","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2010.08.010_bb0115","first-page":"419","article-title":"Mortality in Danish patients with nonmelanoma skin cancer, 1978\u20132001","volume":"159","author":"Jensen","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejim.2010.08.010_bb0120","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1182\/blood-2008-04-151076","article-title":"Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma","volume":"112","author":"Kristinsson","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2010.08.010_bb0125","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-0609.1998.tb01075.x","article-title":"The risk of bacteremia in patients with monoclonal gammopathy of undetermined significance","volume":"61","author":"Gregersen","year":"1998","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ejim.2010.08.010_bb0130","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4065\/84.8.685","article-title":"Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17.398 patients","volume":"84","author":"Bida","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ejim.2010.08.010_bb0135","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders; a report of the International Myeloma Working Group","volume":"121","author":"International Myeloma Working Group","year":"2003","journal-title":"Br J Haematol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620510001834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620510001834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T00:23:58Z","timestamp":1544228638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620510001834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0953620510001834"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2010.08.010","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}